Lorlatinib is safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma, research shows Isra Zaman5 April 2023 9:30 AM ISTNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells, often appearing as a solid tumor in the chest or abdomen. The...
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients Dr. Kamal Kant Kohli4 April 2023 10:00 AM ISTUSA: Immunotherapy after surgery increases the chance of staying cancer-free in bladder cancer patients compared to those who received a placebo,...
Outcome of patients with a rare type of astrocytoma is worse than expected: Study Isra Zaman4 April 2023 9:15 AM ISTGliomas are a tumor that originate in the glial cells that surround neurons in the brain. Under the microscope, gliomas can be divided into several...
Therapy that overcomes chemotherapy resistance in colon and rectal cancer validated in study Isra Zaman3 April 2023 9:15 AM ISTOxaliplatin along with other medications is often used to treat advanced colon or rectal cancer. A multidisciplinary team made up of doctors and...
CAR T cells improve patient quality of life: Study Isra Zaman1 April 2023 9:15 AM ISTChimeric antigen receptor T-cell (CAR-T) therapies are developed by harvesting a patient's own T cells (the immune system's primary cancer-killing...
Some melanoma patients with leptomeningeal disease benefit from novel immunotherapy delivery approach Isra Zaman31 March 2023 9:15 AM ISTLeptomeningeal disease is a complication of cancer that occurs when cancer cells from primary tumors migrate into the cerebrospinal fluid (CSF) and...
Novel drug combination shows positive results for HPV-negative patients with advanced head and neck cancer Isra Zaman30 March 2023 9:15 AM ISTHead and neck cancer is a deadly form of cancer that arises in the lining of the mouth and throat. Worldwide more than 700,000 people were diagnosed...
Novel probe for labeling macrophages associated with cancer progression using a selective dye Isra Zaman29 March 2023 9:45 AM ISTM1 and M2 are activated macrophages that protect our immune system and maintain homeostasis. Interestingly, they are characterized by distinct and...
Clinical trial of ENZAMET shows it promising as prostate cancer treatment Isra Zaman29 March 2023 9:30 AM ISTA new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. The results from the clinical trial of...
Cancer cells with thicker glycocalyx barrier are better at evading immune cells: Study Isra Zaman28 March 2023 9:45 AM ISTCancer cells often form the glycocalyx with high levels of cell-surface mucins, which are thought to help protect the cancer cell from immune cell...
Two promising molecular targets for drug development in recurrent and metastatic cervical cancer identified in new study Isra Zaman28 March 2023 9:30 AM ISTRecurrent cervical cancer may manifest itself in the form of a local recurrence or a metastatic disease. When cancer spreads from part of its origin...
Enhanced recovery feasible after partial nephrectomy of renal malignancies Dr Kartikeya Kohli27 March 2023 8:00 PM ISTIn the partial nephrectomy of renal malignancies, enhanced recovery after surgery (ERAS) is secure and efficient, says an article published in...
